Search results
22 lut 2022 · To assess the efficacy, tolerability and safety of cannabis‐based medicines, including medical cannabis, for treating pain and other symptoms in adults with cancer.
Clinicians should recommend against using cannabis or cannabinoids as a cancer-directed treatment unless within the context of a clinical trial. Cannabis and/or cannabinoids may improve refractory, chemotherapy-induced nausea and vomiting when added to guideline-concordant antiemetic regimens.
The Breast Cancer Risk Assessment Tool (BCRAT), also known as The Gail Model, allows health professionals to estimate a woman's risk of developing invasive breast cancer over the next five years and up to age 90 (lifetime risk).
13 mar 2018 · The Breast Cancer Risk Assessment Tool (BCRAT) , also known as the Gail model, was the most widely used appraisal tool for predicting the absolute risk of developing breast cancer. Individuals with 5-year risk exceeding 1.67% were considered high risk [ 3 ].
24 lut 2021 · The Gail model, created in 1989 by Cruzoé et al., (2015) is used worldwide to predict the risk of developing breast cancer in women within the next five years and over the lifetime.
6 mar 2023 · The MASCC panel recommends against the use of cannabinoids as an adjuvant analgesic for cancer pain and suggests that the potential risk of harm and adverse events be carefully considered for all cancer patients, particularly with treatment with a checkpoint inhibitor.
1 lis 2023 · open access. Highlights. •. This study chronologically reviews breast cancer risk prediction models, emphasizing their latest versions. •. It underscores advancements in genetic testing, which have driven models incorporating polygenic risk scores (PRS). •.
